MCA logo



Ixekizumab (Taltz) for the Treatment of Plaque Psoriasis

ixekizumab (Taltz) plaque psoriasis

Psoriasis is a common skin disease with a global prevalence of 2-3%, and affects over 40,000 people in Singapore. The chronic inflammatory condition with . . .

Sign Up or Log In as a healthcare professional to read the full article.

Share via

Also worth reading

People also read:

World Sleep Day 2023
World Sleep Day 2023

The purpose of World Sleep Day is to raise awareness of the importance of sleep and the impact that sleep has on our health and well-being

Read More »